Day: June 1, 2021

Karolinska Development’s portfolio company Dilafor presents positive results from a phase 2b study of tafoxiparin

Written by Customer Service on June 1, 2021. Posted in Public Companies.

STOCKHOLM, SWEDEN 1 June 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company Dilafor has concluded a phase 2b study with its drug candidate tafoxiparin which showed a significant positive impact on cervical ripening in first-time mothers receiving treatment to induce labor. Further and full analysis of data will be done by the company. Market analyses show that a drug that can induce cervical ripening has the potential to reach annual sales in excess of USD 1 billion in the US market alone. Karolinska Development will obtain an external assessment of how the positive study results affect the book value of its holding in Dilafor. About a quarter of all pregnant women are subject to labor induction, however more than half of these experience failed induction. This leads to a prolonged birth...

Visionstate Reports Q2 2021 Results Highlighted by Growing Revenues and Profitability

Written by Customer Service on June 1, 2021. Posted in Earnings Releases And Operating Results.

EDMONTON, Alberta, June 01, 2021 (GLOBE NEWSWIRE) — Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), a company that develops, and invests in the research and development of, promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability, is pleased to announce its second consecutive profitable quarter for the period ended March 31, 2021. Highlights of the Second Quarter of 2021 include:Total Revenue of $227,663 representing a tenfold increase compared to $20,256 during the same period in 2020. Gross Profit (Loss) of $225,218 compared to ($18,702) during the same period in 2020. Net Income (Loss) of $31,763 compared to ($192,572) during the same period in 2020.To review the financial statements and MD&A for the quarter, please click here. The development and subsequent...

Myriad Genetics Completes the Sale of Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

SALT LAKE CITY, June 01, 2021 (GLOBE NEWSWIRE) — On May 28, 2021, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, completed the sale of its wholly-owned subsidiary, Myriad myPath, LLC, which owns the laboratory that offers the myPath Melanoma test, to Castle Biosciences, Inc for $32.5 million in cash. About Myriad Genetics Myriad Genetics, is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties...

Instil Bio to Present at the Jefferies Virtual Healthcare Conference

Written by Customer Service on June 1, 2021. Posted in Public Companies.

DALLAS, June 01, 2021 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that management will present a company overview at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 9:30 a.m. ET. A live webcast of the presentation may be accessed at: https://wsw.com/webcast/jeff174/til/1707183 or by visiting the News & Events section of the Instil Bio website at www.instilbio.com. An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation. About Instil Bio Instil Bio, Inc. (Nasdaq: TIL) is a clinical-stage biopharmaceutical company focused on developing tumor...

Applied Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Written by Customer Service on June 1, 2021. Posted in Public Companies.

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 at 1:20 p.m. ET. Webcast information for this event will be accessible on the Events page under the Investor Relations section of the Applied Therapeutics website at www.appliedtherapeutics.com. A replay will also be available following the webcast. About Applied Therapeutics Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical...

Evelo Biosciences Announces Appointment of Mark Plinio as Chief Commercial Officer

Written by Customer Service on June 1, 2021. Posted in Public Companies.

CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Mark Plinio as Chief Commercial Officer, effective June 14, 2021. Mr. Plinio brings significant pharmaceutical sales and marketing leadership to Evelo, including experience building and managing blockbuster brands through all stages of commercialization. “We are pleased to welcome Mark to Evelo as we look forward to key milestones across our broad portfolio of SINTAX medicines, and continue building our team for the future,” said Simba Gill, Ph.D., Chief Executive Officer of Evelo. “Mark’s leadership and broad experience launching blockbuster products will be essential as we build the late-stage development and...

Mirasol Resources Signs LOI for its Libanesa Project in Argentina

Written by Customer Service on June 1, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to announce it has entered into a binding letter of intent (“LOI”) with Golden Arrow Resources Corporation (TSX-V: GRG) (“Golden Arrow”) granting to Golden Arrow an option (the “Option”) to acquire a 75% undivided interest in Mirasol’s Libanesa project (“Libanesa”) in Santa Cruz province, Argentina. Under the terms of the LOI, Golden Arrow may exercise the Option by incurring certain exploration expenditures and making staged cash payments over six years. Mirasol’s President, Tim Heenan stated: “Libanesa is an advanced exploration project with multiple attractive drill targets. Golden Arrow has been a successful explorer in Argentina for well over a decade and will be a strong...

CLA Advises on Sale of Earth Development to Crosswalk Capital

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

CLA’s investment banking team advises on sale of outsourced outdoor facility management solutions provider Earth Development to Crosswalk Capital.“We knew what Justin and Katie were looking to achieve with the sale, both from financial and non-financial perspectives,” said Ben Axelrod, managing director and group head of CLA’s investment banking practice. “We designed and executed our process so that Justin and Katie could have strong options to consider while staying true to their post-transaction objectives. In selecting Crosswalk as the ultimate buyer, Justin and Katie found an optimal mix of value recognition and realization of their non-financial goals.”Green Bay, WI, June 01, 2021 (GLOBE NEWSWIRE) — Earth Development, Inc. (“EDI” or the “Company”), a fast-growing provider of outsourced outdoor facility management...

Green Thumb Closes on Acquisition of Massachusetts Cannabis Operator Liberty Compassion Inc.

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

Expands Production Capacity and Further Scales Brand Distribution Capabilities Acquisition Includes One Fully Operational Production Facility and Two Medical Cannabis Retail Stores Expands Retail Locations in Massachusetts to Three; 58 Retail Locations Across the CountryCHICAGO and VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced that it has closed on an acquisition of Liberty Compassion, Inc. (“Liberty”), a Massachusetts-based medical cannabis cultivator and retailer. The acquisition adds cultivation and production capacity and two operating medical cannabis dispensaries located in Boston and West Springfield. “We are thrilled to broaden...

Clarus to Acquire Rhino-Rack, Premier Aftermarket Automotive Roof Rack and Accessories Brand

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

– Transformative Acquisition Aligns with Clarus’ Global “Super Fan” Strategy and Expected to Add Significant Scale, Global Reach and Compelling Growth Opportunities – – Acquisition Expected to be Immediately Accretive – SALT LAKE CITY, June 01, 2021 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor and consumer enthusiast markets, today announced it has entered into a definitive agreement to acquire Australia-based Rhino-Rack Pty Ltd (“Rhino-Rack”), a leading manufacturer and distributor of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, and accessories, for an aggregate purchase price of approximately $USD 198 million ($AUD 255 million). Rhino-Rack will continue to operate independently...

Day: June 1, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals